Morepen Laboratories Limited has informed the Exchange regarding a press release dated August 04, 2026, titled ""Morepen clocks highest-ever quarterly revenue and earnings in Q1 FY27; EBITDA grows by 207% and PAT by 394%; CDMO enters full scale commercialization"".